Nippon India Pharma Fund - Direct (G) vs Tata Money Market Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs Tata Money Market Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

7.4%

stock2

Tata Money Market Fund - Direct (G)

6.47%

Loading chart...

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Deutsche Bank HDFC CitiBank N.A. Standard Chartered Bank

CAMS Ltd. Karvy Computershare P Ltd MCS Ltd.

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

Low to Moderate Risk

5000

33899.06

0.18

5161.3905

January 1, 2013

0

14.01 %

19.35 %

7.4 %

6.75 %

7.52 %

6.47 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Amit Somani

B.Com, PGDBM and CFA Charterholder

Sep 2012 - till date with Tata Asset Management Ltd. as a Fund Manager reporting to Head-Fixed Income. Jun 2010 - Aug 2012 with Tata Asset Management Ltd. as a Credit Analyst reporting to Head of Fixed Income. September 2006 - April 2010 with Fidelity Investments as Research Associate. July 2004 to August 2006 with Netscribes Pvt. Ltd as Research analyst. Jun 2003 to July 2004 with SPA Capital as debt market dealer. February 2001 to May 2003 with Khandwala Securities as debt market dealer.

Marzban Irani

B.Com., PGDBM.

Prior to joining LIC Mutual Fund he was associated with DSP BlackRock Investment Managers (Jun 2014-Jul 2016) as VP Fixed Income, Tata Asset Management (Jun 2011-May 2014) as Senior Fund Manager Fixed Income, MetLife India Insurance (Sep 2010-May 2011) as Fund Manager Fixed Income, Mirae Asset Global Investment Management India Pvt. Ltd. (Jan 2008-Jul 2010) as Fund Manager Fixed Income and Tata Asset Management Limited (Sep 2000-Nov 2007) as Fund Manager Fixed Income.

Get your FAQs right